Yahoo · Oct 9, 2026
Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $423.96, signifying a +2.06% move from its prior day's close.
NYSE · ISRG
Intuitive Surgical, Inc.
Healthcare · Medical - Instruments & Supplies
$423.96
Up+$8.55 (+2.06%)
Updated Oct 10, 2026, 9:08 PM
SID Score
5.2/10
Composite research score
Smart Money
33/100
Bearish
- Market cap
- 195.51B
- P/E ratio
- 71.05
- Dividend yield
- 0.00%
- 52-week range
- $328.57 – $603.88
- Volume
- 1.76M
- Avg. volume
- 2.26M
Price performance · ISRG
ISRG price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
ISRG closed at $423.96 after 21 trading sessions, up 14.85% for the selected period.
- Last close
- $423.96
- Period change
- +14.85%
- Period low
- $369.15
- Period high
- $423.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $416.39 | $427.53 | $415.855 | $423.96 | 1.76M |
| Oct 8, 2026 | $411.60 | $416.72 | $407.70 | $415.41 | 2.53M |
| Oct 7, 2026 | $405.07 | $416.81 | $404.20 | $414.52 | 1.9M |
| Oct 6, 2026 | $405.20 | $409.34 | $402.00 | $404.76 | 1.65M |
| Oct 5, 2026 | $389.76 | $407.63 | $389.11 | $406.48 | 1.66M |
| Oct 2, 2026 | $405.15 | $406.47 | $391.39 | $391.95 | 1.83M |
| Oct 1, 2026 | $409.05 | $410.5199 | $399.25 | $401.24 | 1.51M |
| Sep 30, 2026 | $408.05 | $410.74 | $405.51 | $406.63 | 1.66M |
| Sep 29, 2026 | $411.90 | $414.2043 | $407.07 | $412.18 | 1.89M |
| Sep 28, 2026 | $405.18 | $416.51 | $402.75 | $414.79 | 2.57M |
| Sep 25, 2026 | $397.645 | $406.39 | $391.92 | $405.18 | 2.5M |
| Sep 24, 2026 | $396.725 | $404.19 | $395.18 | $399.52 | 1.57M |
| Sep 23, 2026 | $400.88 | $404.44 | $396.05 | $398.30 | 1.69M |
| Sep 22, 2026 | $403.00 | $403.97 | $397.72 | $402.09 | 1.86M |
| Sep 21, 2026 | $393.89 | $403.48 | $391.04 | $401.65 | 2.97M |
| Sep 18, 2026 | $381.51 | $394.91 | $379.50 | $393.33 | 4.93M |
| Sep 17, 2026 | $385.57 | $388.20 | $378.2801 | $383.54 | 2.39M |
| Sep 16, 2026 | $378.00 | $387.29 | $377.16 | $382.29 | 2.14M |
| Sep 15, 2026 | $374.54 | $379.11 | $368.8501 | $377.16 | 1.98M |
| Sep 14, 2026 | $374.60 | $378.58 | $372.15 | $377.94 | 2.43M |
| Sep 11, 2026 | $363.56 | $374.48 | $363.56 | $369.15 | 3.35M |
Latest ISRG news
The latest Smart Investors Daily articles mentioning ISRG.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ISRG research
Overview
Company profile and research snapshot.
Company profile
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $618.00
- Implied upside
- —
- Analysts
- 23
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 7, 2026 | Barclays | Overweight | — |
| Sep 8, 2026 | BTIG | Buy | — |
| Aug 12, 2026 | Oppenheimer | Outperform | — |
| Jul 30, 2026 | HSBC | Hold | — |
| Jul 17, 2026 | Mizuho | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 8, 2026
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Yahoo · Oct 8, 2026
The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying
A 26% price drop on a stock with a near-monopoly business model and 85% recurring revenue sounds like a warning, but one investor sees it as an invitation to keep buying.
ChartMill · Oct 8, 2026
Intuitive Surgical (NASDAQ:ISRG) Combines Strong Growth With a Constructive Technical Setup
Intuitive Surgical shows strong growth, top-tier profits, and a technical setup that could signal a breakout. See the full ISRG stock analysis.
AI research layers
Interpretive context generated from the platform’s current data sources.
Intuitive Surgical Stock Performance
Intuitive Surgical shares closed at $423.96, declining 0.85% in the most recent session, per SID market data. The stock has demonstrated strong short-term momentum with a 17.6% gain over the past month, though it remains down 28.05% year-over-year. ISRG currently trades above its 50-day moving average of $384.68, suggesting near-term bullish momentum, but sits below its 200-day moving average of $435.80, indicating the longer-term trend remains under pressure. The 14-day RSI reads 64.0, approaching but not yet reaching overbought territory. The company carries a beta of 1.686, according to Massive/Polygon data, reflecting significantly higher volatility than the broader market. Average daily trading volume stands at approximately 2.26 million shares. Intuitive Surgical's market capitalization is approximately $195.5 billion, positioning it among the largest companies in the Healthcare sector by market value.
Intuitive Surgical Valuation Analysis
Intuitive Surgical trades at a price-to-earnings ratio of 71.05, reflecting a significant premium relative to the broader Healthcare sector, per SID market data. The company's PEG ratio stands at 13.30, suggesting the current valuation substantially exceeds what earnings growth projections alone would typically support. The price-to-book ratio of 11.53, according to SEC filings, further underscores the market's willingness to assign a premium multiple to Intuitive Surgical's dominant position in robotic-assisted surgery. The company does not pay a dividend, directing capital instead toward research, development, and operational expansion. At a market capitalization of $195.5 billion, ISRG commands one of the highest valuations in the medical device industry. These elevated multiples reflect the company's established market leadership and recurring revenue model through instruments and accessories, though they leave limited margin for any operational underperformance relative to growth expectations.
Smart Money Activity for ISRG
Intuitive Surgical's composite smart money score stands at 33 out of 100, generating a bearish signal, per SID market data. Institutional positioning is the strongest component at 25 out of 25, indicating robust fund-level ownership and accumulation. However, insider activity scores only 2.0 out of 25, driven by a notable imbalance in recent transactions. According to SEC Form 4 filings, there have been 13 insider trades in the last 90 days, comprising 10 sells against just 3 buys, reflecting a clear pattern of insider distribution. Dark pool activity registers at 5.0 out of 25, suggesting limited off-exchange institutional buying interest at current price levels. Congressional trading activity scores 0.8 out of 25, indicating negligible legislative interest in the stock. The divergence between strong institutional holdings and weak insider sentiment creates a mixed signal, with the overall composite leaning bearish based on the preponderance of insider selling and subdued dark pool flows.
Intuitive Surgical Earnings Outlook
Intuitive Surgical has delivered consecutive earnings beats in its two most recently reported quarters, according to company earnings reports. In the most recent quarter, ISRG posted earnings per share of $2.80 against a consensus estimate of $2.41, representing a positive surprise of $0.39, or approximately 16.2%. The prior quarter saw an even larger beat, with actual EPS of $2.50 versus the $1.92 estimate, a $0.58 surprise amounting to a 30.2% outperformance. Looking ahead, analyst estimates project EPS of $2.41 for the upcoming quarter with results expected on July 21, 2026. The subsequent quarter carries an estimate of $2.54 with a reporting date of October 20, 2026. The consistent pattern of exceeding expectations by double-digit percentages suggests analysts may be conservatively modeling the company's procedure volume growth and instrument attachment rates in the current consensus figures.
Wall Street Analyst Ratings for ISRG
Wall Street coverage of Intuitive Surgical reflects a moderately constructive but mixed outlook, per SID consensus data. Barclays initiated coverage on October 7, 2026, with an Overweight rating, adding a fresh bullish voice to the coverage universe. BTIG reiterated its Buy rating on September 8, 2026, maintaining conviction in the company's growth trajectory. Oppenheimer upgraded ISRG to Outperform on August 12, 2026, shifting from a prior Perform rating, signaling improved confidence following recent results. However, not all analysts share the optimism. HSBC downgraded the stock to Hold from Buy on July 30, 2026, according to Wall Street analyst reports, while Mizuho maintained its Neutral stance on July 17, 2026. Among the five most recent ratings actions, three carry bullish designations while two reflect neutral positioning. No analyst has issued a Sell or Underperform rating in this recent coverage cycle, suggesting a floor of consensus support despite valuation concerns at current levels.
